PI
Pharmstandard International Portfolio holdings
AUM $29M
1-Year Return
2.12%
This Quarter Return
-6.41%
1 Year Return
+2.12%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$81.9K
AUM Growth
-$33.3M
(-100%)
Cap. Flow
+$10.1K
Cap. Flow
% of AUM
12.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
ALNA
Allena Pharmaceuticals, Inc. Common Stock
ALNA
|
+$10.4K |
Top Sells
| 1 |
ARGS
Argos Therapeutics, Inc.
ARGS
|
+$298 |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARGS
1
DELISTED
Argos Therapeutics, Inc.
ARGS
| $39.4K | 40.54% |
657,139
-4,975
| -0.8% | -$298 |
|
2
Protagonist Therapeutics
PTGX
$3.63B
| $20.4K | 21.01% |
982,270
| – | – |
|
|
ALNA
3
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $10.4K | 10.73% |
+1,037,267
| New | +$10.4K |
|
|
JNCE
4
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $8.44K | 8.68% |
662,063
| – | – |
|
5
Protara Therapeutics
TARA
$122M
| $3.17K | 3.26% |
41,698
| – | – |
|